文献速递主动脉疾病

血管腔内动脉瘤修复术中经皮与开放入路的随机多中心试验(PiERO)

Randomized multicenter trial on percutaneous versus open access in endovascular aneurysm repair (PiERO).
PubMed 文献 · J Vasc Surg · 2018-10-03

这项随机多中心试验将适合EVAR的腹主动脉瘤患者随机分配至经皮或开放股总动脉入路,主要结局为手术部位感染数。两组各137个腹股沟,开放组SSI率1.5% vs 经皮组0%,差异无统计学意义;经皮入路疼痛评分更低、2周伤口评估更优。

要点

  • 经皮股总动脉入路未减少EVAR术后手术部位感染数(开放组1.5% vs 经皮组0%)。
  • 经皮入路调整后疼痛评分较开放入路低0.69分。
  • 术后2周伤口评估经皮入路更优(OR 3.57,95%CI 1.02-12.44,P=.046)。

核心结论

  • 经皮股总动脉入路不减少手术部位感染数,但减轻疼痛并改善EVAR术后1天和2周的伤口愈合、减少炎症。

研究设计与样本

  • 随机多中心试验,将适合EVAR的腹主动脉瘤患者随机分配至开放或经皮股总动脉入路置入主体装置,对侧使用与主体随机结果相反的入路技术。
  • 两组各含137个腹股沟,所有患者术前均行筛查培养和腹股沟活检标本采集。

主要发现

  • 手术部位感染率开放组1.5% vs 经皮组0%。
  • 仅主体装置的手术部位感染率开放组3.1%(比值比3.3,95%置信区间0.31-347,P=.34)。
  • 两组伤口并发症相当。
  • 鼻腔或腹股沟金黄色葡萄球菌携带对手术部位感染、Southampton伤口评估评分或视觉模拟量表评分均无显著影响。
  • 调整后疼痛评分经皮入路较开放入路低0.69分。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In endovascular valve and aortic repair, vascular access through a percutaneous approach has become the competing technique to an open surgical approach. The effect on postoperative complications and surgical site infections (SSIs) has been investigated, but randomized evidence is lacking. The objective was to investigate whether percutaneous access of the common femoral artery (CFA) with a percutaneous closure device would decrease the number of SSIs compared with open surgical access of the CFA in endovascular aneurysm repair (EVAR). METHODS: Patients with an abdominal aortic aneurysm suitable for EVAR were randomized to open or percutaneous access of the main device (MD) through the CFA. Through the contralateral side, access was obtained with the other technique than the one for which the MD was randomized. The primary outcome was number of SSIs. Secondary outcomes were wound complications, visual analog scale for pain scores, and standardized wound assessment scores during follow-up. Preoperative screening culture and groin biopsy specimens were obtained from all patients. RESULTS: Both groups contained 137 groins. SSI rate was 1.5% in the open group vs 0% in the percutaneous group. For MDs only, SSI rate was 3.1% (odds ratio, 3.3; 95% confidence interval, 0.31-347; P = .34). Wound complications were comparable in both groups. Neither nasal nor groin Staphylococcus aureus carriage had a significant effect on SSIs, Southampton Wound Assessment score, or visual analog scale score. Adjusted pain score was 0.69 lower, in favor of percutaneous access. Wound assessment was better after 2 weeks (odds ratio, 3.57; 95% confidence interval, 1.02-12.44; P = .046), also in favor of percutaneous access. CONCLUSIONS: Percutaneous access of the CFA does not reduce the number of SSIs. It does, however, reduce pain and improve wound healing with less inflammation 1 day and 2 weeks after EVAR, respectively.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Vierhout BP, Pol RA, Ott MA, et al. Randomized multicenter trial on percutaneous versus open access in endovascular aneurysm repair (PiERO). J Vasc Surg. 2018. PMID: 30292613. doi:10.1016/j.jvs.2018.07.052

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。